Transcat, Inc. $TRNS Shares Sold by Riverbridge Partners LLC

Riverbridge Partners LLC cut its stake in Transcat, Inc. (NASDAQ:TRNS) by 17.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 337,505 shares of the scientific and technical instruments company’s stock after selling 69,708 shares during the quarter. Riverbridge Partners LLC’s holdings in Transcat were worth $19,147,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. State of Alaska Department of Revenue purchased a new stake in shares of Transcat in the third quarter worth about $40,000. Lazard Asset Management LLC acquired a new position in Transcat during the 2nd quarter worth approximately $54,000. PNC Financial Services Group Inc. lifted its position in Transcat by 1,118.2% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,072 shares of the scientific and technical instruments company’s stock worth $92,000 after acquiring an additional 984 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in Transcat by 245.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock worth $97,000 after acquiring an additional 798 shares during the period. Finally, Jones Financial Companies Lllp grew its position in Transcat by 79.2% in the third quarter. Jones Financial Companies Lllp now owns 1,634 shares of the scientific and technical instruments company’s stock valued at $120,000 after acquiring an additional 722 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Transcat Trading Up 0.4%

NASDAQ:TRNS opened at $73.24 on Friday. The stock has a market cap of $683.33 million, a price-to-earnings ratio of 86.16 and a beta of 0.71. Transcat, Inc. has a one year low of $50.23 and a one year high of $97.08. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.85 and a current ratio of 2.21. The business’s 50-day simple moving average is $71.82 and its 200 day simple moving average is $66.99.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Tuesday, February 3rd. The scientific and technical instruments company reported $0.26 earnings per share for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.04). Transcat had a net margin of 2.47% and a return on equity of 6.15%. The business had revenue of $83.86 million for the quarter, compared to analyst estimates of $80.99 million. As a group, sell-side analysts predict that Transcat, Inc. will post 2.3 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 4th. Weiss Ratings restated a “sell (d+)” rating on shares of Transcat in a research note on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $105.33.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.